| Key Financial Ratios of Shasun Pharmaceuticals (in Rs. Cr.) |
Mar 15 |
Mar 14 |
Mar 13 |
Mar 12 |
Mar 11 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
6.94 |
6.22 |
4.76 |
10.92 |
-7.34 |
|
| Diluted EPS (Rs.) |
6.77 |
6.22 |
4.76 |
10.76 |
-7.34 |
|
| Cash EPS (Rs.) |
13.01 |
12.96 |
10.23 |
14.11 |
-2.36 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
68.91 |
55.78 |
50.73 |
47.11 |
35.33 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
68.91 |
55.78 |
50.73 |
47.11 |
35.33 |
|
| Dividend / Share(Rs.) |
0.00 |
1.00 |
1.50 |
2.40 |
0.30 |
|
| Revenue from Operations/Share (Rs.) |
179.36 |
165.07 |
138.24 |
133.50 |
116.82 |
|
| PBDIT/Share (Rs.) |
21.09 |
17.96 |
14.44 |
16.78 |
11.31 |
|
| PBIT/Share (Rs.) |
14.96 |
11.23 |
8.85 |
12.29 |
6.32 |
|
| PBT/Share (Rs.) |
7.62 |
4.94 |
4.17 |
6.76 |
1.72 |
|
| Net Profit/Share (Rs.) |
6.88 |
6.22 |
4.64 |
9.63 |
-7.34 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
11.76 |
10.88 |
10.44 |
12.56 |
9.68 |
|
| PBIT Margin (%) |
8.34 |
6.80 |
6.40 |
9.20 |
5.41 |
|
| PBT Margin (%) |
4.24 |
2.99 |
3.01 |
5.06 |
1.47 |
|
| Net Profit Margin (%) |
3.83 |
3.76 |
3.35 |
7.20 |
-6.28 |
|
| Return on Networth / Equity (%) |
9.97 |
11.15 |
9.14 |
20.43 |
-20.79 |
|
| Return on Capital Employed (%) |
7.05 |
7.03 |
6.72 |
16.67 |
-15.10 |
|
| Return on Assets (%) |
3.13 |
3.07 |
2.87 |
7.44 |
-6.31 |
|
| Total Debt/Equity (X) |
1.26 |
1.55 |
1.29 |
0.83 |
1.14 |
|
| Asset Turnover Ratio (%) |
81.75 |
81.51 |
85.53 |
103.31 |
100.43 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
0.96 |
0.90 |
0.85 |
0.96 |
0.93 |
|
| Quick Ratio (X) |
0.67 |
0.62 |
0.57 |
0.68 |
0.61 |
|
| Inventory Turnover Ratio (X) |
5.10 |
5.08 |
5.39 |
6.65 |
5.41 |
|
| Dividend Payout Ratio (NP) (%) |
0.00 |
16.07 |
32.32 |
22.45 |
-4.08 |
|
| Dividend Payout Ratio (CP) (%) |
0.00 |
7.71 |
14.65 |
15.31 |
-12.72 |
|
| Earnings Retention Ratio (%) |
100.00 |
83.93 |
67.68 |
77.55 |
104.08 |
|
| Cash Earnings Retention Ratio (%) |
100.00 |
92.29 |
85.35 |
84.69 |
112.72 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
2,749.62 |
879.60 |
745.38 |
668.76 |
0.00 |
|
| EV/Net Operating Revenue (X) |
2.55 |
0.94 |
0.95 |
0.91 |
0.00 |
|
| EV/EBITDA (X) |
21.68 |
8.65 |
9.11 |
7.23 |
0.00 |
|
| MarketCap/Net Operating Revenue (X) |
2.07 |
0.43 |
0.48 |
0.63 |
0.00 |
|
| Retention Ratios (%) |
100.00 |
83.92 |
67.67 |
77.54 |
104.08 |
|
| Price/BV (X) |
5.38 |
1.27 |
1.32 |
1.77 |
0.00 |
|
| Price/Net Operating Revenue |
2.07 |
0.43 |
0.48 |
0.63 |
0.00 |
|
| Earnings Yield |
0.02 |
0.09 |
0.07 |
0.12 |
0.00 |
|
Source : Dion Global Solutions Limited
